New Zealand markets closed

Bristol-Myers Squibb Company (BMY)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
41.93+0.89 (+2.17%)
At close: 04:00PM EDT
41.88 -0.05 (-0.12%)
After hours: 07:59PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
45,534,000
45,006,000
46,159,000
46,385,000
42,518,000
Cost of revenue
11,059,000
10,693,000
10,137,000
9,940,000
11,773,000
Gross profit
34,475,000
34,313,000
36,022,000
36,445,000
30,745,000
Operating expenses
Research development
9,673,000
9,299,000
9,509,000
10,195,000
11,143,000
Selling general and administrative
8,377,000
7,772,000
7,814,000
7,690,000
7,661,000
Total operating expenses
27,198,000
26,118,000
26,918,000
27,908,000
28,568,000
Operating income or loss
7,277,000
8,195,000
9,104,000
8,537,000
2,177,000
Interest expense
1,303,000
1,166,000
1,232,000
1,334,000
1,420,000
Total other income/expenses net
-11,820,000
1,411,000
-159,000
895,000
-7,628,000
Income before tax
-5,846,000
8,440,000
7,713,000
8,098,000
-6,871,000
Income tax expense
289,000
400,000
1,368,000
1,084,000
2,124,000
Income from continuing operations
-6,135,000
8,040,000
6,345,000
7,014,000
-8,995,000
Net income
-6,148,000
8,025,000
6,327,000
6,994,000
-9,015,000
Net income available to common shareholders
-6,148,000
8,025,000
6,327,000
6,994,000
-9,015,000
Basic EPS
3.97
3.88
2.97
3.25
-3.99
Diluted EPS
3.94
3.86
2.95
3.12
-3.99
Basic average shares
2,089,500
2,069,000
2,130,000
2,153,000
2,258,000
Diluted average shares
2,100,250
2,078,000
2,146,000
2,245,000
2,258,000